Research programme: ezatiostat analogues - MabVax

Drug Profile

Research programme: ezatiostat analogues - MabVax

Latest Information Update: 10 Oct 2014

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Telik
  • Developer MabVax Therapeutics
  • Class Small molecules
  • Mechanism of Action Glutathione transferase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Preclinical Haematological malignancies; Neutropenia

Most Recent Events

  • 14 Nov 2011 Preclinical pharmacodynamics data presented at the 23rd AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
  • 05 Apr 2011 Preclinical trials in Haematological malignancies in USA (unspecified route)
  • 05 Apr 2011 Preclinical trials in Neutropenia in USA (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top